Class II · Moderate risk
Methylprednisolone Acetate Injectable Suspension
Lack of Assurance of Sterility
Is Methylprednisolone recalled?
Yes — there is an active recall. 5 ongoing FDA recalls mention Methylprednisolone (93 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Methylprednisolone. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Methylprednisolone recalls on record
none so far in 2026; 93 on record, newest first
Class II · Moderate risk
Methylprednisolone Acetate/Bupivacaine Hydrochloride Injectable Suspension
Lack of Assurance of Sterility
Class II · Moderate risk
Methylprednisolone Acetate/Bupivacaine Hydrochloride Injectable Suspension
Lack of Assurance of Sterility
Class III · Low risk
methylPREDNISolone Sodium Succinate For Injection
Labeling: Incorrect Instructions: Vial label incorrectly instructs healthcare professional to reconstitute product with 16 mL rather than the correct volume of 8 mL of Bacteriostatic Water for Injection with Benzyl Alcohol.
Class II · Moderate risk
Methylprednisolone 10 Mg / 0.16 Ml Ivp
Lack of Assurance of Sterility
Class II · Moderate risk
MethylPREDNISolone Tablets
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Class II · Moderate risk
MethylPREDNISolone Tablets
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Class II · Moderate risk
MethylPREDNISolone Tablets
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Class II · Moderate risk
MethylPREDNISolone Tablets
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Class II · Moderate risk
MethylPREDNISolone Tablets
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Class II · Moderate risk
Methylprednisolone 1% PF Ophthalmic
Lack of sterility assurance.
Class III · Low risk
MethylPREDNISolone Tablets
Failed Stability Specifications: An out-of-specification result was obtained during 18-month stability testing for assay.
Class II · Moderate risk
methylPREDNISolone Sodium Succinate for Injection
Failed Impurities/Degradation Specifications: High out of specification results for an impurity.
Class II · Moderate risk
methylPREDNISolone Sodium Succinate for Injection
Failed Impurities/Degradation Specifications: High out of specification results for an impurity.
Class II · Moderate risk
methylPREDNISolone Sodium Succinate for Injection
Failed Impurities/Degradation Specifications: High out of specification results for an impurity.
Class II · Moderate risk
methylPREDNIsolone ACETATE
Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.
Class II · Moderate risk
Methylprednisolone Acetate 80 mg/mL
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
Class II · Moderate risk
Methylprednisolone Acetate 40 mg/mL
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
Class II · Moderate risk
Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection
Lack of Processing Controls: Isomeric Pharmacy Solution, LLC announces a voluntary field action for the Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection because the sterile injectable products were sterilized too long leading to potential difficulty resuspending particles.
Class III · Low risk
Methylprednisolone Tablets
Labeling: Incorrect or Missing Lot and/or Exp Date: incorrect expiration date of 02/0218 is printed on the container label instead of the correct expiration date of 02/2018.
Class II · Moderate risk
Solumedrol
Lack of Assurance of Sterility: Product sterility cannot be guaranteed.
Class II · Moderate risk
Methylprednisolone/Lidocaine
Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.
Class II · Moderate risk
MethylPREDNISolone PF
Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.
Class II · Moderate risk
MethylPREDNISolone
Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.
Class II · Moderate risk
All Products Intended to be Sterile
Lack of Assurance of Sterility
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.